Klogenix

Klogenix is a preclinical-stage biotechnology company based in Boston, aiming to prevent and treat age-related diseases and extend healthy lifespan. Since its establishment, the company has been focusing on Klotho resilience and longevity genes. Klogenix has taken the lead in developing several advanced models for upregulating endogenous Klotho and delivering exogenous Klotho genetic material.